Two Rezdiffra patients talking
Two Rezdiffra patients talking

Understanding MASH

Your liver needs your attention.

Even with your best efforts, your fatty liver disease could actually be MASH with liver scarring.

MASH was formerly called NASH (nonalcoholic steatohepatitis).

You can have MASH with liver scarring and not know it, so it's important to manage your liver health.

Fatty liver with caution icon

Fatty liver disease can silently become MASH.

MASH is a serious form of fatty liver disease that occurs when fat in the liver becomes toxic, causing inflammation and scarring. A test for liver scarring can tell you if your fatty liver disease has progressed.

Weight scale icon

Managing fatty liver disease or MASH requires more than just losing weight.

People of all sizes can develop fatty liver disease and MASH. While nutrition and exercise play an important role in helping to manage these conditions, weight loss doesn't always prevent progression or reduce MASH.

MASH Progression

How do fatty liver disease and MASH progress?

If you have fatty liver disease, it could actually be MASH with liver scarring, so it's important to know your disease stage.

Select each stage to learn more.

Marker 1: Healthy liver Marker 2: Fatty liver Marker 3: MASH Marker 4: MASH scarring Marker 5: Cirrhosis
Healthy liver image

Healthy liver

Healthy liver zoom in image

Healthy liver

A healthy liver may have a small amount of fat (less than 5% of the liver’s weight). It performs its main functions properly, which includes processing the body's food and waste.

Fatty liver image

Fatty liver

Fatty liver zoom in image

Fatty liver

The fat content in the liver has accumulated to more than 5%. This fat buildup can damage the liver if left unchecked and unmanaged.

A test at this stage can reveal if liver damage is silently worsening.

Liver with MASH image

MASH

Liver with MASH zoom in image

MASH

Fibrosis stage

The fat buildup in your liver has become toxic, triggering inflammation. This is damaging and could lead to scarring (also known as fibrosis). MASH without scarring is considered fibrosis stage F0.

A test for liver scarring can tell you if there is any scarring in your liver.

Liver with MASH and scarring image

MASH + scarring

Liver with MASH and scarring zoom in image

MASH + scarring

Fibrosis stage

Toxic fat buildup and chronic inflammation have led to more severe damage to the liver. MASH with scarring is a serious condition that can lead to irreversible damage. A liver with mild scarring is considered fibrosis stage F1. Moderate to advanced scarring is stages F2-F3; Rezdiffra is indicated for stages F2-F3.

F3 is the last stage before cirrhosis. It is critical to talk to your liver specialist.

Liver with cirrhosis image

Cirrhosis

Liver with cirrhosis zoom in image

Cirrhosis

Fibrosis stage

Severe scarring has permanently and irreversibly damaged the liver. Cirrhosis may lead to liver failure, liver cancer, and reduced life expectancy. A liver with cirrhosis is considered stage F4, the most advanced stage of fibrosis.

The damage to your liver is irreversible. A liver transplant is the only definitive option to restore full liver function once the liver has decompensated.

Serious Consequences

MASH is serious and can progress to life‑threatening consequences.

Healthy liver with caution icon

Did you know: Latinos may be at greater risk of developing MASH?

People of Latino descent are more likely to have a genetic marker that makes them more susceptible to storing fat in their liver. It's called the PNPLA3 gene variant. This gene variant can increase the likelihood of developing MASH and for it to be more severe, so it is important to get tested for liver scarring. See tests below.

Types of tests

Ask for a test for liver scarring to understand your liver health.

Even if you've had a blood test for liver enzymes or an ultrasound, you may need other tests to measure fat buildup and scarring linked to MASH. If your test results reveal you have stage 2 or 3 liver scarring (fibrosis stage F2 or F3) without cirrhosis, ask your liver specialist if Rezdiffra is right for you.

Select each test to learn more.

Ask for a test for liver scarring.

ALT=alanine transaminase; AST=aspartate aminotransferase; ELF=enhanced liver fibrosis; FIB-4=Fibrosis-4; MRI=magnetic resonance imaging.

Liver specialist icon

Ask a liver specialist about Rezdiffra and if it is right for you.

Talk to your liver specialist today.

Important Safety Information and Indication

Expand Collapse

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.

Important Safety Information and Indication

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.